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ABSTRACT
Objectives: We investigated all-cause mortality and risk factors of death of patients with unrup-
tured intracranial aneurysms (UIAs) in a long-term follow-up study.
Methods: A total of 142 patients with 181 UIAs diagnosed between 1956 and 1978 when UIAs
were not treated were included in this study. Patients were followed until death or until 2011 to
2012. Mortality rates and risk factors were studied with Kaplan-Meier survival analysis and the
Cox proportional hazards regression models.
Results: During 3,530 person-years, 113 (80%) had died, giving an average annual mortality of
3.2%. Of them, 19 (17%) died of aneurysm rupture from the index UIA, 6 (5%) of other
aneurysm-related causes, and 2 (2%) of unspecified subarachnoid hemorrhage. The remaining
86 died of causes unrelated to intracranial aneurysms. The cumulative death rate was 20%
(95% confidence interval 14%–27%) at 10 years and 60% (52%–68%) at 30 years. Indepen-
dent risk factors for subsequent death were patient age (adjusted hazard ratio 1.09 per year,
95% confidence interval 1.05–1.12, p, 0.001), male sex (2.81, 1.59–4.96, p, 0.001), heavy
alcohol use (4.22, 2.22–8.02, p, 0.001), and cigarette smoking (1.72, 0.97–3.07, p5 0.064).
History of hypertension, family history of subarachnoid hemorrhage, and diameter of UIA pre-
dicted death only in univariable analysis.
Conclusions: In patients of working age with a UIA, alcohol consumption and cigarette smoking
are modifiable risk factors for untimely death through several causes and should be taken into
account when treatment is considered. Neurology® 2015;84:456–463
GLOSSARY
BP 5 blood pressure; CI 5 confidence interval; HR 5 hazard ratio; SAH 5 subarachnoid hemorrhage; UIA 5 unruptured
intracranial aneurysm.
Saccular intracranial aneurysms develop during the lifetime in 3% of the population.1 Of these,
approximately 25%, or nowadays even less, ever rupture.2 Rupture of an aneurysm results in
subarachnoid hemorrhage (SAH) with a high case fatality rate.3–5
Those who survive 1 year after SAH seem to have almost 2-fold-higher mortality rate during
subsequent decades as compared with the general population.5–7 This excess mortality is heter-
ogeneous but is mostly attributable to vascular events including ischemic cerebrovascular stroke,
poor outcome after SAH, sequelae of SAH, nonocclusion of ruptured aneurysms, or SAH from
another aneurysm.5,7 Patients with untreated and even treated unruptured intracranial aneur-
ysms (UIAs) seem also to have long-term excess mortality compared with the general popula-
tion.8,9 This elevated mortality rate is likely attributable to both aneurysm ruptures and other
cerebrovascular events.8,9
This elevated mortality rate of aneurysm patients mainly because of cerebrovascular diseases
and subsequent new SAH episodes may be explained by the risk factors smoking, hypertension,
and excessive alcohol drinking.10 UIAs, most of which (65%–85%) are,7 mm in diameter, are
now increasingly discovered.2,4 To estimate effectiveness of a preventive intervention, it is
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essential to know, in addition to the risk of
aneurysm rupture, also the life expectancy
and risk factors for the observed excess
mortality.
Unruptured aneurysms were not operated
on in Finland before 1979.2 This long-term
natural history study reports all-cause mortal-
ity and risk factors for death in patients of
working age with UIAs covering almost the
whole of their remaining life.
METHODS Patients. The series included 142 patients with
UIAs diagnosed between 1956 and 1978 at the Department of Neu-
rosurgery, Helsinki University Central Hospital, which was the only
neurosurgical center in Finland until 1967 and remained responsible
for neurosurgical services for 60% to 88% of the Finnish population
between 1967 and 1978.2 For the detailed baseline characteristics of
the 142 patients, see our previous reports.2,11,12 Most patients (n 5
131) were those with multiple aneurysms in whom only the rup-
tured one was clipped and occlusion was confirmed by postoperative
angiography. Verification of the ruptured aneurysm was based on
the signs of rupture in the surgical record.11 Additional evidence for
the identification of ruptured aneurysm in these patients was as
follows11: the greater size of the ruptured aneurysm in 10 patients;
the size with a secondary sac in 69 patients; intracerebral hematoma
caused by the ruptured aneurysm in 38 patients; and oculomotor
palsy associated with a ruptured internal carotid artery aneurysm in
14 patients. Patients with SAH and 2 or more aneurysms of equal
size but without other evidence indicating which aneurysm had bled
were treated conservatively and excluded from this study. Angiog-
raphies in the remaining 11 patients discovered either incidental
(n5 5; chronic headache, nausea, dizziness, visual disorders) or symp-
tomatic (n 5 6; cranial nerve deficits or cerebral infarction) UIAs.11
Follow-up methods. Follow-up evaluation was performed
mainly by means of repeated postal questionnaires and telephone
interviews obtained from patients and close relatives every 10 years
from the 1960s onward.2,11–15 During the previous follow-up
evaluations, the patients were interviewed (S.J.) by means of a
structured questionnaire eliciting data on patient characteristics,
previous diseases and hospital visits, use of medicines, and health
habits.11–13 For the recording of blood pressure (BP) values, see
our previous reports.11,13 Those who were alive between 1996 and
1998 were also interviewed in the outpatient clinic and a follow-
up CT angiogram was performed.12 New questionnaires were
filled in between 2011 and 2012 based on telephone interviews
either with patients or with relatives on demand.13 Alcohol
consumption was recorded at the beginning of the follow-up in
grams of absolute ethanol consumed within 1 week (standard
drink 12 g of alcohol). Cigarette smoking was categorized as
follows: never a smoker, formerly a regular cigarette smoker
(quit before or during the follow-up), and current cigarette
smoker. A family history of aneurysms was defined as $2
verified ruptured aneurysm cases in first-degree relatives.2,13
Information on all the patients was also obtained from the
medical records of other hospitals and general practitioners to
confirm the accuracy of the data concerning diseases, medicines,
and BP readings.11,13 UIAs without any rupture were occluded in
3 patients between 1997 and 1999 after follow-ups of 24.4 to
25.9 years.2 Of 34 UIAs that ruptured during the follow-up, 16
were occluded after a rupture. Of these patients, 15 were con-
scious and one was in deep coma.16 Autopsy reports and official
death certificates from the Causes of Death Register (Statistics
Finland) were examined for all the deceased patients. In Finland,
a statutory medicolegal autopsy is performed on all those who die
due to trauma or unknown cause (Act on the Inquest into the
Cause of Death, 459/1973, Finnish Law). The follow-up was
complete.
Standard protocol approvals, registrations, and patient
consents. All patients gave their written informed consent. The
approval for the surveys and follow-up data collection has been
obtained from the local ethics committee and in compliance
with national legislation and the Declaration of Helsinki.
Statistical analysis. The data were analyzed with the IBM SPSS
Statistics 22.0 for Windows (IBMCorp., Armonk, NY). Categor-
ical variables were compared using Fisher exact 2-tailed test or the
Pearson x2 test, while the continuous variables were compared
between groups using the Mann–Whitney U test or t tests.
For the life-table analysis and the Cox proportional hazards
regression model, each patient was followed up until death or the
last contact between 2011 and 2012. The average annual mortality
was calculated by dividing the number of deaths by the number of
person-years in the follow-up. Cumulative rates of death were esti-
mated using the Kaplan-Meier product-limit method, and the
curves for the groups were compared using the log-rank test.
Cox proportional hazards regression with a backward stepwise
procedure (removal if p . 0.1) and Wald statistics was used to
determine hazard ratios (HRs) and 95% confidence intervals
(CIs) for several variables in predicting death. These variables,
which were known at the beginning of the follow-up, were the
following: age, sex, maximum aneurysm diameter, location of the
largest UIA in each patient, presence of multiple UIAs, type of
aneurysm (symptomatic or incidental vs those with prior SAH),
cigarette-smoking status and current smoking, alcohol consump-
tion, a family history of ruptured intracranial aneurysms, a history
of hypertension (systolic BP .140 or diastolic BP .90 mm Hg
or use of antihypertensive medication), and BP (systolic, diastolic,
mean) values. Interactions between significant predictors of death
were tested to see the extent to which they deviated from the
additive effects of the main risk factors. The proportionality
assumption was checked. The test of significance was based on
changes in the log (partial) likelihood. A 2-tailed p value ,0.05
was considered statistically significant.
RESULTS Patient characteristics. Association of sub-
sequent deaths with the baseline characteristics of
the patient population is shown in table 1. Patient
age (p , 0.05), approximate amount of alcohol con-
sumed within 1 week (p , 0.05), and particularly
heavy alcohol consumption (p, 0.01) were associated
with subsequent death, as were male sex (p 5 0.062)
and smoking status (p 5 0.086) but without reaching
significance. Those who were active smokers the entire
follow-up time had a higher death rate compared with
others (p 5 0.016), but current smokers at the
beginning of follow-up had not because quitters
accumulated among those who were alive at the end
of follow-up.Men smoked more frequently both at the
beginning (74% vs 42%, p , 0.001) and at the end
(60% vs 36%, p 5 0.01) of follow-up, and they were
also more frequently heavy alcohol drinkers (38% vs
4%, p , 0.001) than women.
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At the beginning of follow-up, age by sex was similar
(mean 6 SD age for men 42.2 6 9.2 years vs for
women 43.0 6 10.1 years). At the end of follow-up,
patient age was 66.6 6 13.4 years (for men 62.5 6
12.4 years and for women 70.2 6 13.2 years, p ,
0.001). Mean6 SD age of 113 patients who had died
was 64.06 13.1 years (range 33.9–93.6 years; for men
60.2 6 11.6 and for women 67.9 6 13.6 years, p ,
0.01) and that of those who were alive was 77.06 8.6
years (for men 77.06 5.7 years and for women 76.96
9.8 years). Age at death was higher (p, 0.001) in those
without SAH from UIA than in those with aneurysm
rupture (66.66 13.3 vs 56.56 9.3 years). Those who
had died of unrelated causes (65.9 6 13.2 years; for
men 61.0 6 11.8 years and for women 71.5 6 12.6
years, p, 0.001) outlived those who died of SAH from
UIA (53.76 6.7 years; for men 52.06 5.0 years and
for women 54.5 6 7.4 years) by approximately 12
years (p, 0.001), even more in women (by 17 years).
Cumulative rates and causes of death. Annual and
cumulative death rates according to baseline charac-
teristics are shown in table 2. Patient age, male sex,
cigarette smoking, and heavy alcohol consumption
(p , 0.01) as well as hypertension (p 5 0.052) and
family history of ruptured aneurysms (p 5 0.073)
increased cumulative mortality. Survival curves of
those with later SAH from UIA and those without
are shown in figure e-1 on the Neurology® Web site at
Neurology.org. Curves did not differ significantly
because not all patients with an aneurysm rupture
die of SAH. However, mortality of those younger
than 41 years was significantly higher if a UIA
ruptured during the follow-up (figure e-2). Men,
cigarette smokers, and heavy alcohol drinkers had
higher mortality rates (p , 0.01) than others
(figures e-3 to e-5). Prior SAH as well as the size,
location, and multiplicity of UIAs did not predict
subsequent death.
Table 1 Baseline characteristics of patients at the beginning of follow-up, grouped by subsequent death
during follow-up
Characteristic Deceased (n 5 113) Alive (n 5 29) All patients (n 5 142)
Women, n (%) 56 (50) 20 (69) 76 (54)
Age, mean 6 SD, y 42.9 6 9.9a 37.6 6 9.6 41.8 6 10.1
Body mass index, mean 6 SD, kg/m2 25.8 6 3.8 26.4 6 4.2 25.9 6 3.9
Blood pressure, mean 6 SD, mm Hg 141 6 19/85 6 10 135 6 15/85 6 9 140 6 19/85 6 10
History of hypertension, n (%) 43 (38) 8 (28) 51 (36)
Smoking status (n 5 123), n (%)
No 27 (29) 10 (34) 37 (30)
Quit before follow-up 9 (10) 6 (21) 15 (12)
Quit during follow-up 8 (9) 5 (17) 13 (11)
Current 50 (53)a 8 (28) 58 (47)
Alcohol consumption (n 5 95)
Median (range), g/wk 70 (0–1,000)a 2 (0–350) 20 (0–1,000)
‡300 g/wk, n (%) 19/66 (29)b 1/29 (3) 20/95 (21)
Family history of aneurysms (n 5 94), n (%) 8 (12) 1 (3) 9 (10)
Diameter of largest aneurysm, n (%)
£6 mm 92 (81) 24 (83) 116 (82)
‡7 mm 21 (19) 5 (17) 26 (18)
Location of largest aneurysm, n (%)
Internal carotid artery 47 (42) 13 (45) 60 (42)
Anterior cerebral artery 5 (4) 1 (3) 6 (4)
Anterior communicating artery 6 (5) 2 (7) 8 (6)
Middle cerebral artery 52 (46) 12 (41) 64 (45)
Vertebrobasilar artery 3 (3) 1 (3) 4 (3)
Multiple unruptured aneurysms, n (%) 28 (25) 5 (17) 33 (23)
History of hypertension was defined as systolic pressure repeatedly .140 mm Hg or diastolic pressure .90 mm Hg, or as
use of antihypertensive medication. Aneurysm size 5 largest diameter in millimeters. Family history of aneurysms was
defined as $2 verified ruptured aneurysm cases in first-degree relatives.
ap , 0.05 and bp , 0.01 for difference between groups.
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The mean follow-up time per patient was 24.9
years (median 24.2, range 0.8–52.3 years). Of the
142 patients, 113 (80%) had died during the
follow-up of 3,530 person-years, yielding an average
annual mortality of 3.2%. Of the 34 patients with
SAH from previously diagnosed UIA, 18 patients
died of either an aneurysm rupture or rerupture dur-
ing a mean follow-up time of 11.4 years (range 1.4–
24.2 years), and one of late rebleeding 2.9 years after
aneurysm rupture with conservative treatment during
a total follow-up of 20.1 years. Four patients died of
SAH from a nonindex aneurysm (2 patients with
verified de novo aneurysms and 2 with aneurysms
diagnosed with follow-up CT angiograms but with-
out having previous vertebral angiographies) during a
mean follow-up of 28.5 years (range 13.4–51.0
years). Two patients aged 42.7 and 49.6 years died
of typical SAH but without angiograms or autopsy
12.7 and 13.6 years after controlled occlusions of
ruptured aneurysms, which were previously diag-
nosed index UIAs. One patient died of expansion
of an unruptured giant aneurysm but without rupture
and another patient aged 58.4 years died of SAH
caused by fracture of aneurysm clip 24.0 years after
Table 2 Annual and cumulative death rates, grouped by factors known at the beginning of follow-up
Characteristic No. of patients Annual death rate, % (n)
Cumulative death rates, % (95% CI)
10 y 20 y 30 y
All patients 142 3.2 (113/3,530) 20 (14–27) 39 (31–47) 60 (52–68)
Prior SAH
No 11 3.6 (8/225) 46 (16–75) 55 (25–84) 64 (35–92)
Yes 131 3.2 (105/3,305) 18 (12–25) 37 (29–46) 60 (51–68)
Sexa
Men 66 4.0 (57/1,408) 24 (14–35) 52 (39–64) 76 (65–86)
Women 76 2.6 (56/2,121) 17 (9–26) 28 (18–38) 46 (35–57)
Age, ya
£30 25 2.5 (19/757) 12 (0–25) 24 (7–41) 52 (32–72)
31–40 40 2.3 (27/1,173) 10 (1–19) 25 (12–38) 48 (32–63)
41–50 46 3.5 (38/1,101) 20 (8–31) 39 (25–53) 61 (47–75)
51–60 31 5.8 (29/498) 42 (24–59) 68 (51–84) 81 (67–95)
History of hypertension
No 91 2.9 (70/2,455) 19 (11–27) 31 (21–40) 52 (41–62)
Yes 51 4.0 (43/1,074) 24 (12–35) 53 (39–67) 75 (63–86)
Current cigarette smokinga
No 53 2.2 (37/1,672) 4 (0–9) 19 (8–29) 42 (28–55)
Yes 70 3.4 (57/1,672) 20 (11–29) 43 (31–54) 63 (52–74)
Alcohol consumptiona
<300 g/wk 75 1.9 (47/2,469) 1 (0–4) 13 (6–21) 35 (24–45)
‡300 g/wk 20 5.4 (19/352) 35 (14–56) 70 (50–90) 85 (69–100)
Family history of aneurysms
No 85 2.2 (57/2,578) 8 (2–14) 22 (13–31) 42 (32–53)
Yes 9 3.5 (8/229) 22 (0–49) 33 (3–64) 56 (23–88)
Diameter of unruptured aneurysm
£6 mm 116 3.1 (92/2,989) 18 (11–25) 35 (26–43) 58 (49–67)
‡7 mm 26 3.9 (21/540) 31 (13–49) 58 (39–77) 69 (51–87)
Multiple unruptured aneurysms
No 109 3.1 (85/2,785) 20 (13–28) 38 (29–47) 58 (49–67)
Yes 33 3.8 (28/744) 21 (7–35) 42 (26–59) 67 (51–83)
Abbreviations: CI 5 confidence interval; SAH 5 subarachnoid hemorrhage.
Annual death rate is calculated by dividing the number of deceased patients by person-years of follow-up shown in parentheses.
ap , 0.01 for difference of cumulative mortality between groups (log-rank test).
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treatment of a ruptured aneurysm. The remaining 86
died of unrelated causes (31 of cardiovascular diseases,
14 of cerebrovascular diseases, 21 of malignant neo-
plasms, and 20 of other diseases or traumas).
Causes of death of 113 patients according to sex,
cigarette smoking, and heavy alcohol consumption
are shown in table 3. Men died of cardiovascular
causes more frequently than women (p 5 0.024)
and heavy alcohol drinkers more frequently of trauma
or suicide than others (p 5 0.042). Furthermore,
women died nonsignificantly more likely of SAH,
cerebrovascular diseases, and malignancies, smokers
of SAH, and heavy drinkers of SAH and liver cirrhosis
but less likely of malignancies, probably because they
were relatively young at the time of death.
Other causes of untimely deaths were primary
intracerebral hemorrhage (mean age 57.1, range
50.6–64.2 years), trauma or suicide (46.1, 33.9–
71.3 years), and hepatic cirrhosis (48.2, 40.7–55.6
years). However, those who died of SAH caused by
de novo aneurysm or aneurysm verified during the
follow-up were older (mean 70.5, range 63.4–80.2
years).
Risk factors for death. Univariable and multivariable
HRs for the risk factors known at the beginning of
the follow-up are shown in table 4. In univariable
analysis, patient age (particularly older than 50
years), male sex, cigarette smoking, and heavy
alcohol consumption were risk factors for death
(p , 0.01). History of hypertension, family history
of ruptured aneurysms, and diameter of UIA as a
continuous variable did not reach significance. In
multivariable analysis, age and male sex were
independent risk factors for death. Current cigarette
smoking at the beginning of follow-up also increased
the risk for death (table 4; model I). When heavy
alcohol consumption was included in the multivariable
model, age, male sex, and heavy drinking were
independent significant predictors of subsequent death
(table 4; model II). Current cigarette smoking was not
an independent predictor (p 5 0.12) because it was
closely correlated with the alcohol consumption (p ,
0.001). There were no significant interactions between
the independent risk factors for death.
All those with missing data for either cigarette
smoking or alcohol consumption were dead at the
end of follow-up. If all patients with missing smoking
status (n 5 19) are considered nonsmokers, current
cigarette smokers at the beginning of follow-up still
had almost significant increased risk of death after
adjustment for age and sex (adjusted HR 1.45,
95% CI 0.97–2.16, p5 0.068). If those with missing
alcohol status (n 5 47) are considered also to be
nondrinkers, heavy drinking was still a risk factor
for death after adjustment for sex, age, cigarette
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smoking, hypertension, and aneurysm diameter
(2.09, 1.22–3.58, p 5 0.008).
DISCUSSION The patient’s age, male sex, heavy
alcohol consumption, and cigarette smoking seem,
from the present results, to be independent risk fac-
tors for death among patients of working age with
UIAs. Nonsmokers and nondrinkers outlived current
smokers and heavy drinkers by approximately 10 to
20 years. History of hypertension or family history of
ruptured aneurysms and size of aneurysm had only
trend in univariable analysis for increased mortality.
Survivors 1 year after SAH as well as those with
both untreated and possibly also treated UIAs seem
to have higher mortality during subsequent decades
as compared with the general population.5–9 This
excess mortality is attributable to both aneurysm-
related and -unrelated causes. Our study demon-
strated that the ruptures from untreated UIAs
accounted for 17% of all deaths and intracranial
aneurysms including also ruptures from nonindex
aneurysms (e.g., de novo aneurysms) and their seque-
lae for 24%. Distribution of aneurysm-unrelated
causes of death was similar to general Western pop-
ulations. Mortality caused by a rupture of a diagnosed
untreated UIA seems to be important because SAH
causes only 0.6% of all deaths in Finland (approxi-
mately 300 SAH deaths/50,000 all annual deaths;
Table 4 Risk factors for all-cause death
Characteristic
No. of
patients
Univariable HR
(95% CI)
Multivariable HR (95% CI)
Model I Model II
Sex
Women 76 1.00 1.00 1.00
Men 66 1.74 (1.19–2.53)a 2.32 (1.30–4.17)a 3.00 (1.41–6.40)a
Age, y
<31 25 1.00
31–40 40 0.98 (0.54–1.79)
41–50 46 1.71 (0.96–3.03)
>50 31 3.50 (1.89–6.47)a
Continuous, per year 142 1.05 (1.03–1.07)a 1.07 (1.03–1.10)a 1.10 (1.06–1.15)a
History of hypertension
No 91 1.00 1.00
Yes 51 1.46 (1.00–2.15)b 1.00 (0.55–1.82) 0.90 (0.44–1.85)
Current smoking
No 53 1.00 1.00 1.00
Yes 70 1.88 (1.23–2.88)a 1.89 (1.09–3.28)c 1.67 (0.88–3.19)
Alcohol consumption
<300 g/wk 75 1.00 1.00
‡300 g/wk 20 4.31 (2.48–7.51)a 3.98 (1.68–9.43)a
Alcohol consumption, per 100 g/wk 95 1.38 (1.23–1.55)a
Family history of aneurysms
No 85 1.00 1.00 1.00
Yes 9 1.96 (0.93–4.16)d 1.12 (0.48–2.57) 1.42 (0.56–3.63)
Diameter of unruptured aneurysm
£6 mm 116 1.00
‡7 mm 26 1.36 (0.85–2.19)
Continuous, per mm 142 1.06 (0.99–1.12)d 0.99 (0.87–1.12) 0.84 (0.70–1.02)
Abbreviations: CI 5 confidence interval; HR 5 hazard ratio.
In multivariable analyses, the HRs were adjusted for the other variables listed in the table.
ap , 0.01.
bp 5 0.053.
cp , 0.05.
dp 5 0.08.
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Statistics Finland). This is also supported by our pre-
vious observation of the lifelong rupture risk of 30%
irrespective of aneurysm size among patients younger
than 50 years.2,17
Apart from being indisputable modifiable risk fac-
tors for SAH,10 cigarette smoking and heavy alcohol
drinking seem to be main risk factors for all-cause
mortality of patients with UIA, even much more
important than aneurysm-associated factors. After
inclusion of deceased patients with missing values
for alcohol and smoking variables as nonsmokers
and nondrinkers in models, smoking and heavy
drinking were still important risk factors for death.
These habits were also clearly more common in men
than in women. However, this only partly explained
the higher mortality rate in men because adjustment
by these factors did not abolish the significant differ-
ence of mortality rates between men and women.
Cardiovascular deaths seemed to account for the
excess mortality among men. Although hypertension
is the main risk factor for cardiovascular diseases, it
unexpectedly did not predict independently the risk
for subsequent mortality likely because of several rea-
sons: (1) BP values correlated with age, (2) BP values
were recorded at the beginning of follow-up and
likely varied during the very long-lasting follow-up,
(3) the patient population was relatively young and
hypertension may be more important in older pa-
tients, and (4) all patients already had aneurysms,
which are known to be associated with increased prev-
alence of hypertension.
Cigarette smoking and excess alcohol consumption
increase premature death rate through several causes,
e.g., cardiovascular and cerebrovascular events, some
malignant neoplasms, liver cirrhosis, and trauma.18–20
Alcohol consumption is an important contributor to
mortality and potential years of life lost, particularly in
Europe. The average life expectancy of heavy alcohol
drinkers is clearly lower than that of cigarette smokers
because mortality caused by alcohol consumption occurs
primarily among people of working age (approximately
5% of all deaths in people younger than 60 years).18–20
Compared with other risk factors (cigarette smoking,
cholesterol, or hypertension), the alcohol-attributable
disease burden is more important in younger people.19
The life expectancy is considerably shorter for men than
for women. Much of the difference can be explained by
cigarette smoking and harmful alcohol drinking.21
The strength of our cohort study is its unique
nature with enrollment of patients of working age
during the time when UIAs were not treated and
the long-term follow-up covered the remainder of
the patient’s life in the majority of cases (80%).2,22
There were also only few surgical withdrawals after
a long-term follow-up (.24 years), and the follow-up
of our patients was complete.
A limitation of our study was that the patients
were younger than in the other studies with UIA pa-
tients and mostly had multiple aneurysms, with the
ruptured aneurysm clipped at the start of the
follow-up. However, patients with either a history
of SAH or multiple UIAs have not been shown to
have a higher risk of aneurysm rupture than others
when confounding factors are considered.2,22–24 Finn-
ish people have also been considered to be subject to a
higher risk of aneurysm rupture.22 However, there
were 32 Finns enrolled in the International Study
of Unruptured Intracranial Aneurysms during the
1990s,22,23 but none of them had an aneurysm rup-
ture within more than 200 follow-up years. This sug-
gests that risk factors themselves are much more
important than nationality considering aneurysm
rupture risk. In the present study, missing values for
alcohol consumption and cigarette smoking did not
change the results after considering these in additional
analyses.
When assessing treatment for UIAs, not only
should aneurysm-related risk factors (aneurysm size
and location) be considered but also life expectancy
and the risk factors that shorten the lifespan. The
younger the patient and the larger the aneurysm,
the higher the indications for treatment become.2,4
However, the indication and benefit for treatment
of UIAs in heavy drinkers may be quite questionable
when the risks associated with heavy drinking are
compared with those of the UIA. However, the indi-
cation for UIA treatment seems to be relatively high
in smoking women because they also have a higher
lifelong UIA rupture risk.17 While smoking shortens
life expectancy, it increases risk of UIA rupture, and
women outlive men. Irrespective of treatment indica-
tions, cessation of smoking and excess alcohol drink-
ing and treatment of hypertension are, however,
important for all aneurysm patients.
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Supplemental figure e-1: Cumulative survival curves of those with and without a later 
subarachnoid hemorrhage from diagnosed unruptured aneurysm. 
 
Supplemental figure e-2: Cumulative survival curves of those with and without a later 
subarachnoid hemorrhage from diagnosed unruptured aneurysm according to age groups 
(<41 years vs. vs. vs. ≥41 years). 
 
Supplemental figure e-3: Cumulative mortality in relation to sex. 
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Figure e-1. Cumulative survival curves of those with and without a later subarachnoid 
hemorrhage from diagnosed unruptured aneurysm. 
 
 
 
 
Those who had an aneurysm rupture (red line) had nonsignificantly shorter survival time than others 
(black line) (difference of median survival times of 8.3 years, 18.4 vs. 26.7 years, p=0.154). The 
markers of the curves indicate censored events. SAH= subarachnoid hemorrhage. 
 
 
 
Figure e-2. Cumulative survival curves of those with and without a later subarachnoid 
hemorrhage from diagnosed unruptured aneurysm according to age groups (<41 years vs. vs. 
vs. ≥41 years). 
 
 
 
Those aged <41 years who had an aneurysm rupture (red line) had significantly shorter survival 
time than others aged <41 years (black line) (difference of median survival times of 16.3 years, 20.8 
vs. 37.1 years, p=0.008) while among those aged ≥41 years (green line for those without SAH and 
blue one for those with SAH), the difference was not significant (difference of median survival 
times of 12.8 years, 8.8 vs. 21.5 years, p=0.77). The markers of the curves indicate censored events. 
SAH= subarachnoid hemorrhage. 
Figure e-3. Cumulative mortality in relation to sex. 
 
 
 
 
Kaplan-Meier curves showing cumulative mortality in relation to sex. Men (red line) had a shorter 
survival rate than women (black line)(difference of median survival times of 11.1 years, 19.8 vs. 
30.9 years, p=0.004). The markers of the curves indicate censored events. 
 
 
 
 
Figure e-4. Cumulative survival in relation to cigarette smoking. 
 
 
 
 
Kaplan-Meier curves showing cumulative mortality in relation to current cigarette smoking at the 
beginning of follow-up. Smokers (red line) had a shorter survival rate than nonsmokers (black line) 
(difference of median survival times of 12.0 years; 22.8 vs. 34.8 years, p=0.003). The markers of 
the curves indicate censored events. 
 
 
 
Figure e-5. Cumulative survival in relation to heavy alcohol consumption. 
 
 
 
Kaplan-Meier curves showing cumulative mortality in relation to heavy alcohol consumption at the 
beginning of follow-up. Heavy drinkers (red line) had a shorter survival rate than others (black line) 
(difference of median survival times of 23.0 years; 13.9 vs. 36.9 years, p<0.001). The markers of 
the curves indicate censored events. 
 
